Cargando…
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
Hypercholesterolemia is the main cardiovascular (CV) risk factor with a large body of evidence. Our aim was to assess the achievement of the main therapeutic goal of Low-Density Lipoprotein Cholesterol (LDL-C) in patients with a very high CV risk and a high-dose statin therapy. The study group consi...
Autores principales: | Lis, Anna, Lis, Paulina, Łowicka, Weronika, Grabarczyk, Małgorzata, Wita, Michał, Żarczyński, Piotr, Żarczyńska, Małgorzata, Haberka, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456080/ https://www.ncbi.nlm.nih.gov/pubmed/37623342 http://dx.doi.org/10.3390/jcdd10080329 |
Ejemplares similares
-
Nucleic Acids Persistence—Benefits and Limitations in Forensic Genetics
por: Żarczyńska, Małgorzata, et al.
Publicado: (2023) -
Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017) -
Quality of Life 6 Months after COVID-19 Hospitalisation: A Single-Centre Polish Registry
por: Koźlik, Maciej, et al.
Publicado: (2023) -
Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children
por: Grabarczyk, Małgorzata, et al.
Publicado: (2022) -
Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
por: Klimchak, Alexa C., et al.
Publicado: (2020)